Moreover, ENO1 promotes the occurrence of various cancers, including breast cancer, through the PI3K/AKT pathway, and the PI3K/AKT pathway is also inhibited in liver cancer cells after inhibiting ENO1 [12]. Here, AKT1 is linked to liver cancer.